APA
Steinbach D., Bader P., Willasch A., Bartholomae S., Debatin K., Zimmermann M., Creutzig U., Reinhardt D. & Gruhn B. (20160204). Prospective validation of a new method of monitoring minimal residual disease in childhood acute myelogenous leukemia. : Clinical cancer research : an official journal of the American Association for Cancer Research.
Chicago
Steinbach Daniel, Bader Peter, Willasch Andre, Bartholomae Stephan, Debatin Klaus-Michael, Zimmermann Martin, Creutzig Ursula, Reinhardt Dirk and Gruhn Bernd. 20160204. Prospective validation of a new method of monitoring minimal residual disease in childhood acute myelogenous leukemia. : Clinical cancer research : an official journal of the American Association for Cancer Research.
Harvard
Steinbach D., Bader P., Willasch A., Bartholomae S., Debatin K., Zimmermann M., Creutzig U., Reinhardt D. and Gruhn B. (20160204). Prospective validation of a new method of monitoring minimal residual disease in childhood acute myelogenous leukemia. : Clinical cancer research : an official journal of the American Association for Cancer Research.
MLA
Steinbach Daniel, Bader Peter, Willasch Andre, Bartholomae Stephan, Debatin Klaus-Michael, Zimmermann Martin, Creutzig Ursula, Reinhardt Dirk and Gruhn Bernd. Prospective validation of a new method of monitoring minimal residual disease in childhood acute myelogenous leukemia. : Clinical cancer research : an official journal of the American Association for Cancer Research. 20160204.